Chemoenzymatically Synthesized O ‐Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.202517989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Zhiyong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands. Hauptthemen laut MEDLINE: Gangliosides, Receptors, Virus. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, Health∼Holland, Chinese Scholarship Council.
Abstract (Originalsprache)
Gangliosides are a class of sialic acid‐containing glycosphingolipids involved in a wide range of biological processes. The terminal sialic acid of gangliosides can be O ‐acetylated at C7 and/or C9 hydroxyl, contributing to ganglioside structural complexity and function. It has been difficult to obtain panels of structurally well‐defined O ‐acetylated gangliosides for binding and functional studies. We describe here a chemoenzymatic strategy that can provide, for the first time, 7‐ O ‐, 9‐ O ‐, and 7,9‐di‐ O ‐acetylated GD3 gangliosides. It is based on the chemical assembly of a common tetrasaccharide precursor as α‐glycosyl fluoride that is coupled to sphingosine by a glycosynthase, followed by O ‐acetyl editing by coronaviral hemagglutinin‐esterases (HEs). The resulting synthetic glycosphingolipids have been employed for cell surface remodeling of erythrocytes. Analysis by liquid chromatography and ion mobility mass spectrometry (LC‐IM‐MS) demonstrated successful integration of the glycosphingolipids into the plasma membrane with preservation of acetyl ester patterns. Using human coronavirus HKU1 spike‐functionalized virus‐like particles, we demonstrate that the resulting glycan‐remodeled erythrocytes can be utilized in hemagglutination (HA) studies as a label‐free method to investigate viral protein binding to individual glycoforms in a cellular environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, 3584 CG, The Netherlands.
- Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, 30602, USA.
- Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
- Department of Chemistry, University of Georgia, Athens, Georgia, 30602, USA.
ORCID-Profile: Geert-Jan Boons
Förderung
- European Commission
- Health∼Holland
- Chinese Scholarship Council
Zitieren
APA
Zhang, Z., Liang, R., Hooijschuur, K. C., de Vries, R. P., Li, Z., & Boons, G. J. (2026). Chemoenzymatically Synthesized O ‐Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202517989
Vancouver
Zhang Z, Liang R, Hooijschuur KC, de Vries RP, Li Z, Boons GJ. Chemoenzymatically Synthesized O ‐Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202517989
BibTeX
@article{Zhang2026,
author = {Zhang, Zhiyong and Liang, Ruonan and Hooijschuur, Kevin C and de Vries, Robert P and Li, Zeshi and Boons, Geert-Jan},
title = {Chemoenzymatically Synthesized O ‐Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.202517989}
}
EUVIMED